Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

1 Sept 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 11571566
DOI: 10.1038/sj.gt.3301422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectorsPMID 11571566Read ↗

Current status of gene therapy for α-1 antitrypsin deficiencySemantic proximity Read ↗

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsSemantic proximity Read ↗

Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV2-CB-hAAT) Gene Vector to AAT-Deficient AdultsSemantic proximity Read ↗

Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 <i>α</i> 1-Antitrypsin (AAT) Vector in AAT-Deficient AdultsSemantic proximity Read ↗

Preclinical Characterization of A Recombinant Adeno-Associated Virus Type 1-Pseudotyped Vector Demonstrates Dose-Dependent Injection Site Inflammation And Dissemination of Vector Genomes to Distant SitesSemantic proximity Read ↗

Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production MethodSemantic proximity Read ↗

Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector.Semantic proximity Read ↗

[Current methods for determination of contents of alpha 1 antitrypsin in the human serum applied in clinico-epidemiological studies].Semantic proximity Read ↗

Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients.Semantic proximity Read ↗

Antibody Response to Aerosolized Transgenic Human Alpha1-AntitrypsinSemantic proximity Read ↗

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration.Semantic proximity Read ↗

Criteria for alpha 1-antitrypsin substitution.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.